Hims & Hers Health Inc Financials
Hims & Hers Health Inc (HIMS) reported $2.3B in revenue for fiscal year 2025, up 59.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Operating profitability has arrived, but FY2025 shows growth being funded by heavier reinvestment and much more leverage.
In FY2025, operating cash flow stayed strong at$300M , but free cash flow shrank to$57M . Capital spending reached$243M versus$53M in FY2024, so the cash squeeze came from reinvestment intensity rather than weaker day-to-day cash generation from customers.
Gross margin compression from
Total liabilities rose to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Hims & Hers Health Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Hims & Hers Health Inc has an operating margin of 4.5%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is up from 4.2% the prior year.
Hims & Hers Health Inc's revenue surged 59.0% year-over-year to $2.3B, reflecting rapid business expansion. This strong growth earns a score of 96/100.
Hims & Hers Health Inc has elevated debt relative to equity (D/E of 2.98), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 21/100, reflecting increased financial risk.
Hims & Hers Health Inc's current ratio of 1.90 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.
While Hims & Hers Health Inc generated $300.0M in operating cash flow, capex of $242.6M consumed most of it, leaving $57.4M in free cash flow. This results in a low score of 54/100, reflecting heavy capital investment rather than weak cash generation.
Hims & Hers Health Inc's ROE of 23.7% shows moderate profitability relative to equity, earning a score of 41/100. This is down from 26.4% the prior year.
Hims & Hers Health Inc scores 3.86, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.7B) relative to total liabilities ($1.6B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Hims & Hers Health Inc passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Hims & Hers Health Inc generates $2.34 in operating cash flow ($300.0M OCF vs $128.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Hims & Hers Health Inc generated $2.3B in revenue in fiscal year 2025. This represents an increase of 59.0% from the prior year.
Hims & Hers Health Inc's EBITDA was $160.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 102.7% from the prior year.
Hims & Hers Health Inc reported $128.4M in net income in fiscal year 2025. This represents an increase of 1.8% from the prior year.
Hims & Hers Health Inc earned $0.51 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 3.8% from the prior year.
Cash & Balance Sheet
Hims & Hers Health Inc generated $57.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 71.0% from the prior year.
Hims & Hers Health Inc held $228.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Hims & Hers Health Inc's gross margin was 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 5.6 percentage points from the prior year.
Hims & Hers Health Inc's operating margin was 4.5% in fiscal year 2025, reflecting core business profitability. This is up 0.3 percentage points from the prior year.
Hims & Hers Health Inc's net profit margin was 5.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.1 percentage points from the prior year.
Hims & Hers Health Inc's ROE was 23.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.7 percentage points from the prior year.
Capital Allocation
Hims & Hers Health Inc spent $90.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 8.3% from the prior year.
Hims & Hers Health Inc invested $242.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 359.5% from the prior year.
Not reported for fiscal year 2025.
HIMS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.3B+59.0% | $1.5B+69.3% | $872.0M+65.5% | $526.9M+93.8% | $271.9M+82.8% | $148.8M+80.2% | $82.6M |
| Cost of Revenue | $814.0M | $614.3M+102.5% | $303.4M+93.2% | $157.1M+32.9% | $118.2M+75.4% | $67.4M+71.4% | $39.3M+3.6% | $38.0M |
| Gross Profit | $1.8B | $1.7B+47.8% | $1.2B+64.1% | $714.9M+74.9% | $408.7M+99.9% | $204.5M+86.8% | $109.5M+145.4% | $44.6M |
| SG&A Expenses | $431.9M | $272.7M+62.6% | $167.8M+29.2% | $129.9M+32.3% | $98.2M-46.5% | $183.6M+179.9% | $65.6M+17.4% | $55.9M |
| Operating Income | -$154.5M | $105.6M+70.6% | $61.9M+310.2% | -$29.5M+57.1% | -$68.7M+40.3% | -$115.0M-659.7% | -$15.1M+79.6% | -$74.4M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $10K-97.3% | $369K |
| Income Tax | -$21.6M | -$4.4M+91.8% | -$54.3M-2850.7% | $2.0M+6471.0% | -$31K+99.0% | -$3.1M-2569.3% | $127K+41.1% | $90K |
| Net Income | -$142.0M | $128.4M+1.8% | $126.0M+635.3% | -$23.5M+64.1% | -$65.7M+39.0% | -$107.7M-494.3% | -$18.1M+74.9% | -$72.1M |
| EPS (Diluted) | — | $0.51-3.8% | $0.53+581.8% | -$0.11+65.6% | -$0.32+44.8% | -$0.58 | -$0.51+75.4% | -$2.07 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
HIMS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B+204.5% | $707.5M+60.4% | $441.2M+20.4% | $366.3M-12.9% | $420.6M+254.3% | $118.7M+64.7% | $72.1M |
| Current Assets | $767.6M+93.9% | $395.8M+49.3% | $265.1M+22.4% | $216.6M-19.8% | $269.9M+138.7% | $113.1M+62.5% | $69.6M |
| Cash & Equivalents | $228.6M+3.6% | $220.6M+128.2% | $96.7M+106.7% | $46.8M-34.8% | $71.8M+162.5% | $27.3M+20.7% | $22.6M |
| Inventory | $80.1M+24.4% | $64.4M+186.8% | $22.5M+4.2% | $21.6M+59.0% | $13.6M+282.7% | $3.5M-16.0% | $4.2M |
| Accounts Receivable | $32.1M+426.2% | $6.1M-9.0% | $6.7M+71.8% | $3.9M-4.9% | $4.1M+272.7% | $1.1M | N/A |
| Goodwill | $278.3M+146.9% | $112.7M+1.7% | $110.9M0.0% | $110.9M0.0% | $110.9M | $0 | N/A |
| Total Liabilities | $1.6B+599.1% | $230.8M+137.6% | $97.2M+77.9% | $54.6M-36.5% | $86.0M-67.6% | $265.6M+25.4% | $211.9M |
| Current Liabilities | $404.4M+82.7% | $221.4M+150.2% | $88.5M+84.5% | $47.9M-39.5% | $79.2M+420.2% | $15.2M-26.2% | $20.6M |
| Total Equity | $540.9M+13.5% | $476.7M+38.6% | $344.0M+10.4% | $311.7M-6.8% | $334.6M+327.8% | -$146.9M-5.1% | -$139.8M |
| Retained Earnings | -$113.8M+53.0% | -$242.1M+34.2% | -$368.2M-6.8% | -$344.6M-23.5% | -$279.0M-62.9% | -$171.3M-11.8% | -$153.2M |
Not reported in any period shown, so not listed: Long-Term Debt.
HIMS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $263.4M | $300.0M+19.5% | $251.1M+241.7% | $73.5M+377.0% | -$26.5M+22.9% | -$34.4M-1288.1% | -$2.5M+96.7% | -$74.9M |
| Capital Expenditures | $201.9M | $242.6M+359.5% | $52.8M+99.2% | $26.5M+268.1% | $7.2M | N/A | N/A | N/A |
| Free Cash Flow | $61.5M | $57.4M-71.0% | $198.3M+322.0% | $47.0M+239.3% | -$33.7M | N/A | N/A | N/A |
| Investing Cash Flow | -$902.0M | -$1.0B-5280.9% | -$19.0M-57.3% | -$12.1M-134.9% | $34.7M+122.2% | -$156.3M-293.6% | -$39.7M-1.0% | -$39.3M |
| Financing Cash Flow | $127.3M | $729.6M+776.5% | -$107.8M-839.8% | -$11.5M+65.4% | -$33.1M-114.1% | $235.0M+392.3% | $47.7M-49.9% | $95.3M |
| Share Buybacks | N/A | $90.0M+8.3% | $83.0M+4054.0% | $2.0M | $0 | $0 | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
HIMS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 73.8%-5.6pp | 79.5%-2.5pp | 82.0%+4.4pp | 77.6%+2.3pp | 75.2%+1.6pp | 73.6%+19.6pp | 54.0% |
| Operating Margin | 4.5%+0.3pp | 4.2%+7.6pp | -3.4%+9.7pp | -13.0%+29.3pp | -42.3%-32.1pp | -10.2%+80.0pp | -90.1% |
| Net Margin | 5.5%-3.1pp | 8.5%+11.2pp | -2.7%+9.8pp | -12.5%+27.1pp | -39.6%-27.4pp | -12.2%+75.1pp | -87.3% |
| Return on Equity | 23.7%-2.7pp | 26.4%+33.3pp | -6.8%+14.2pp | -21.1%+11.1pp | -32.2% | N/A | N/A |
| Return on Assets | 6.0%-11.9pp | 17.8%+23.2pp | -5.3%+12.6pp | -17.9%+7.7pp | -25.6%-10.3pp | -15.3%+84.7pp | -100.0% |
| Current Ratio | 1.90+0.1x | 1.79-1.2x | 3.00-1.5x | 4.52+1.1x | 3.41-4.0x | 7.43+4.1x | 3.38 |
| Debt-to-Equity | 2.98+2.5x | 0.48+0.2x | 0.28+0.1x | 0.18-0.1x | 0.26 | N/A | N/A |
| FCF Margin | 2.5%-11.0pp | 13.4%+8.0pp | 5.4%+11.8pp | -6.4% | N/A | N/A | N/A |
Similar Companies
Where Hims & Hers Health Inc Ranks
Frequently Asked Questions
What is Hims & Hers Health Inc's annual revenue?
Hims & Hers Health Inc (HIMS) reported $2.3B in total revenue for fiscal year 2025. This represents a 59.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Hims & Hers Health Inc's revenue growing?
Hims & Hers Health Inc (HIMS) revenue grew by 59.0% year-over-year, from $1.5B to $2.3B in fiscal year 2025.
Is Hims & Hers Health Inc profitable?
Yes, Hims & Hers Health Inc (HIMS) reported a net income of $128.4M in fiscal year 2025, with a net profit margin of 5.5%.
What is Hims & Hers Health Inc's EBITDA?
Hims & Hers Health Inc (HIMS) had EBITDA of $160.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Hims & Hers Health Inc's gross margin?
Hims & Hers Health Inc (HIMS) had a gross margin of 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Hims & Hers Health Inc's operating margin?
Hims & Hers Health Inc (HIMS) had an operating margin of 4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Hims & Hers Health Inc's net profit margin?
Hims & Hers Health Inc (HIMS) had a net profit margin of 5.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Hims & Hers Health Inc's return on equity (ROE)?
Hims & Hers Health Inc (HIMS) has a return on equity of 23.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Hims & Hers Health Inc's free cash flow?
Hims & Hers Health Inc (HIMS) generated $57.4M in free cash flow during fiscal year 2025. This represents a -71.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Hims & Hers Health Inc's operating cash flow?
Hims & Hers Health Inc (HIMS) generated $300.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Hims & Hers Health Inc's total assets?
Hims & Hers Health Inc (HIMS) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Hims & Hers Health Inc's capital expenditures?
Hims & Hers Health Inc (HIMS) invested $242.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Hims & Hers Health Inc's current ratio?
Hims & Hers Health Inc (HIMS) had a current ratio of 1.90 as of fiscal year 2025, which is generally considered healthy.
What is Hims & Hers Health Inc's debt-to-equity ratio?
Hims & Hers Health Inc (HIMS) had a debt-to-equity ratio of 2.98 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Hims & Hers Health Inc's return on assets (ROA)?
Hims & Hers Health Inc (HIMS) had a return on assets of 6.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Hims & Hers Health Inc's Altman Z-Score?
Hims & Hers Health Inc (HIMS) has an Altman Z-Score of 3.86, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Hims & Hers Health Inc's Piotroski F-Score?
Hims & Hers Health Inc (HIMS) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Hims & Hers Health Inc's earnings high quality?
Hims & Hers Health Inc (HIMS) has an earnings quality ratio of 2.34x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Hims & Hers Health Inc?
Hims & Hers Health Inc (HIMS) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.